Concourse Financial Group Securities’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-548
Closed -$51.1K 850
2024
Q4
$51.1K Buy
+548
New +$43.2K ﹤0.01% 1209
2024
Q3
Sell
-16
Closed -$1.13K 2296
2024
Q2
$1.09K Hold
16
﹤0.01% 2109
2024
Q1
$858 Hold
16
﹤0.01% 2155
2023
Q4
$852 Buy
+16
New +$780 ﹤0.01% 2132
2022
Q2
Sell
-437
Closed -$28.7K 2226
2022
Q1
$32K Buy
437
+142
+48% +$9.87K ﹤0.01% 1312
2021
Q4
$21K Buy
295
+64
+28% +$4.65K ﹤0.01% 1613
2021
Q3
$18K Buy
231
+76
+49% +$6.1K ﹤0.01% 1693
2021
Q2
$12K Buy
155
+36
+30% +$2.56K ﹤0.01% 1802
2021
Q1
$7K Buy
119
+22
+23% +$1.39K ﹤0.01% 1870
2020
Q4
$6K Sell
97
-19
-16% -$1.09K ﹤0.01% 1852
2020
Q3
$6K Buy
116
+38
+49% +$1.96K ﹤0.01% 1725
2020
Q2
$4K Buy
78
+24
+44% +$1.16K ﹤0.01% 1753
2020
Q1
$2K Buy
54
+7
+15% +$346 ﹤0.01% 1887
2019
Q4
$3K Hold
47
﹤0.01% 1772
2019
Q3
$2K Buy
47
+19
+68% +$905 ﹤0.01% 1539
2019
Q2
$1K Hold
28
﹤0.01% 2103
2019
Q1
$1K Hold
28
﹤0.01% 2150
2018
Q4
$1K Buy
+28
New +$1.4K ﹤0.01% 2013

Other funds holding GMED

Concourse Financial Group Securities's GMED Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 548 shares — an estimated $51.1K sold.

Concourse Financial Group Securities first reported a position in GMED in Q4 2018 and held it in 18 quarters. The position peaked at $51.1K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 548 Globus Medical shares in Q1 2025, an estimated $51.1K.
  • Concourse Financial Group Securities first reported a position in Globus Medical in Q4 2018 and held it in 18 quarters.
  • Concourse Financial Group Securities's Globus Medical position peaked at $51.1K in Q4 2024.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.